We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVRI icon
11676
CALL
Enviri
NVRI
$630M
$220K ﹤0.01%
13,000
-4,200
-24% -$77.7K
RPTX
11677
CALL
DELISTED
Repare Therapeutics
RPTX
$220K ﹤0.01%
8,400
+1,100
+15% +$35.5K
SLRC icon
11678
CALL
SLR Investment Corp
SLRC
$705M
$220K ﹤0.01%
+11,500
New +$219K
USRT icon
11679
iShares Core US REIT ETF
USRT
$4.6B
$220K ﹤0.01%
+3,757
New +$228K
WCLD
11680
WisdomTree Cloud Computing Fund
WCLD
$286M
$220K ﹤0.01%
3,811
-3,288
-46% -$193K
XNET
11681
PUT
Xunlei
XNET
$322M
$220K ﹤0.01%
76,900
-29,200
-28% -$104K
QTTB icon
11682
PUT
Q32 Bio
QTTB
$482M
$220K ﹤0.01%
1,556
-1,000
-39% -$127K
NAGE
11683
CALL
Niagen Bioscience
NAGE
$241M
$220K ﹤0.01%
35,100
-25,400
-42% -$209K
COOLU
11684
DELISTED
Corner Growth Acquisition Corp. Unit
COOLU
$220K ﹤0.01%
22,040
-341,675
-94% -$3.43M
NIRWW
11685
DELISTED
Near Intelligence, Inc. Warrant
NIRWW
$220K ﹤0.01%
339,009
+182,919
+117% +$128K
HARP
11686
PUT
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$220K ﹤0.01%
2,780
-2,060
-43% -$207K
SBII.WS
11687
DELISTED
Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
SBII.WS
$220K ﹤0.01%
275,000
FLXN
11688
CALL
DELISTED
Flexion Therapeutics, Inc.
FLXN
$220K ﹤0.01%
36,100
+500
+1% +$3.12K
ARDX icon
11689
PUT
Ardelyx
ARDX
$1.2B
$219K ﹤0.01%
166,200
+76,300
+85% +$204K
KMT icon
11690
PUT
Kennametal
KMT
$2.58B
$219K ﹤0.01%
+6,400
New +$230K
LFUS icon
11691
CALL
Littelfuse
LFUS
$11.7B
$219K ﹤0.01%
800
-2,200
-73% -$586K
PDFS icon
11692
PUT
PDF Solutions
PDFS
$1.92B
$219K ﹤0.01%
9,500
-800
-8% -$16.5K
PHI icon
11693
PLDT
PHI
$4.32B
$219K ﹤0.01%
6,736
-3,602
-35% -$97.7K
SLS icon
11694
PUT
SELLAS Life Sciences
SLS
$2.3B
$219K ﹤0.01%
23,900
-9,200
-28% -$85.4K
SPTL icon
11695
CALL
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.6B
$219K ﹤0.01%
+5,300
New +$225K
SUSC icon
11696
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
$219K ﹤0.01%
7,946
-317,030
-98% -$8.84M
NAGE
11697
Niagen Bioscience
NAGE
$241M
$219K ﹤0.01%
34,966
+5,740
+20% +$47.3K
BTEC
11698
DELISTED
Principal Exchange-Traded Funds Principal Healthcare Innovators ETF
BTEC
$219K ﹤0.01%
+4,015
New +$227K
BATT icon
11699
Amplify Lithium & Battery Technology ETF
BATT
$121M
$218K ﹤0.01%
12,681
+1,404
+12% +$24.9K
DAO
11700
PUT
Youdao
DAO
$2.12B
$218K ﹤0.01%
18,000
-23,600
-57% -$322K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.